Creyos

Creyos, formerly known as Cambridge Brain Sciences, embarked on its mission three decades ago, rooted in the pioneering neuroscience research of Dr. Adrian Owen at Cambridge University. The journey began to take a more defined shape in 2009 when Cambridge Brain Sciences was established as a web-based platform. This platform was designed for both the public and the scientific community to assess cognitive functions like memory, attention, verbal ability, reasoning, and planning using Dr. Owen's computerized tests. A significant milestone was achieved in 2010 when Dr. Owen received a $10 million grant, the Canada Excellence Research Chair in Cognitive Neuroscience and Imaging at Western University's Brain and Mind Institute. This funding propelled the rigorous testing and validation of 12 core cognitive tasks, which became the bedrock of the company's offerings. The company, as it's known today, truly started to form in 2014. This was when Dr. Owen partnered with Marc Lipton, a business leader with a strong background in building successful ventures and a personal passion for advancing neuroscience and cognitive care. Together, they envisioned transforming how clinicians and researchers measure brain health by leveraging Dr. Owen's research and digitized cognitive tasks. They assembled a dedicated team of scientists, product designers, and software architects to build the platform.

Since its inception, the platform's normative database of cognitive task scores has grown exponentially, now containing over 12 million scores from individuals aged 6 to 90 and beyond, making it one of the world's largest. The cognitive tasks developed have been utilized and validated in over 400 peer-reviewed scientific studies, predominantly by independent institutions. This underscores the scientific credibility of the assessments, which were well-validated even before the commercial entity was formally established. In 2015, the company was officially founded by Professor Adrian Owen and Marc Lipton. Recognizing the evolution of their services beyond cognitive tasks to include digital versions of standard patient health questionnaires, the company rebranded from Cambridge Brain Sciences to Creyos in 2022. This change reflected their core commitment: ensuring every assessment, report, and insight is rooted in scientific credibility. Today, Creyos serves thousands of healthcare providers across various disciplines, alongside researchers, offering a comprehensive platform to objectively measure and monitor patient brain health, ultimately aiming to improve patient outcomes and develop more effective cognitive care plans.